Majid Ghoddusi serves as the Executive Director of Clinical Biomarkers at Janux Therapeutics, where he plays a pivotal role in the company's innovative pursuits. His extensive expertise in oncology translational and clinical biomarkers distinguishes him as a seasoned professional in the field. With a wealth of experience, he has been instrumental in shaping the development of diverse therapeutic modalities. Majid's proficiency extends to the meticulous design and execution of patient selection strategies, an integral component of modern medical advancements. He has attended biomarkers US as a key speaker.